Gilead Sciences Inc (GILD)
Number of days of payables
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Number of days of payables | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ —
= —
The number of days of payables for Gilead Sciences Inc is not provided in the dataset. Thus, it is not possible to analyze or interpret this specific financial ratio for the company based on the information available. It would be beneficial to obtain the actual data for the number of days of payables in order to evaluate Gilead Sciences Inc's management of its accounts payable effectively.
Peer comparison
Dec 31, 2024
Company name
Symbol
Number of days of payables
Gilead Sciences Inc
GILD
—
ADMA Biologics Inc
ADMA
35.67
Amgen Inc
AMGN
—
Bio-Techne Corp
TECH
20.58
Biogen Inc
BIIB
30.18
Halozyme Therapeutics Inc
HALO
—
Krystal Biotech Inc
KRYS
16.00
Moderna Inc
MRNA
—
Neurocrine Biosciences Inc
NBIX
—
Repligen Corporation
RGEN
—
Vericel Corp Ord
VCEL
—
See also:
Gilead Sciences Inc Average Payables Payment Period (Quarterly Data)